FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2048509532> ?p ?o ?g. }

• W2048509532 endingPage "1839" @default.
• W2048509532 startingPage "1828" @default.
• W2048509532 abstract "Polycystin-2 (PC2 or TRPPC2), a member of the transient receptor potential channel family, is a nonselective calcium channel. Mutations in PC2 are associated with polycystic liver diseases. PC2-defective cholangiocytes show increased production of cyclic adenosine monophosphate, protein kinase A-dependent activation of the extracellular signal-regulated kinase 1/2 (ERK1/2) pathway, hypoxia-inducible factor 1α (HIF-1α)-mediated vascular endothelial growth factor (VEGF) production, and stimulation of cyst growth and progression. Activation of the ERK/HIF-1α/VEGF pathway in cholangiocytes plays a key role during repair from biliary damage. We hypothesized that PC2 levels are modulated during biliary damage/repair, resulting in activation of the ERK/HIF-1α/VEGF pathway. PC2 protein expression, but not its gene expression, was significantly reduced in mouse livers with biliary damage (Mdr2(-/-) knockout, bile duct ligation, 3,5-diethoxycarbonyl-1,4-dihydrocollidine treatment). Treatment of cholangiocytes with proinflammatory cytokines, nitric oxide donors, and endoplasmic reticulum stressors increased ERK1/2 phosphorylation, HIF-1α transcriptional activity, secretion of VEGF, and VEGF receptor type 2 phosphorylation and down-regulated PC2 protein expression without affecting PC2 gene expression. Expression of homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein and NEK, ubiquitin-like proteins that promote proteosomal PC2 degradation, was increased. Pretreatment with the proteasome inhibitor MG-132 restored the expression of PC2 in cells treated with cytokines but not in cells treated with nitric oxide donors or with endoplasmic reticulum stressors. In these conditions, PC2 degradation was instead inhibited by interfering with the autophagy pathway. Treatment of 3,5-diethoxycarbonyl-1,4-dihydrocollidine mice and of Mdr2(-/-) mice with the proteasome inhibitor bortezomib restored PC2 expression and significantly reduced the ductular reaction, fibrosis, and phosphorylated ERK1/2.In response to biliary damage, PC2 expression is modulated posttranslationally by the proteasome or the autophagy pathway, and PC2 down-regulation is associated with activation of ERK1/2 and an increase of HIF-1α-mediated VEGF secretion; treatments able to restore PC2 expression and to reduce ductular reaction and fibrosis may represent a new therapeutic approach in biliary diseases." @default.
• W2048509532 created "2016-06-24" @default.
• W2048509532 creator A5005614526 @default.
• W2048509532 creator A5010510821 @default.
• W2048509532 creator A5013568442 @default.
• W2048509532 creator A5034146725 @default.
• W2048509532 creator A5035712059 @default.
• W2048509532 creator A5058175056 @default.
• W2048509532 date "2015-10-10" @default.
• W2048509532 modified "2023-10-12" @default.
• W2048509532 title "Posttranslational regulation of polycystin-2 protein expression as a novel mechanism of cholangiocyte reaction and repair from biliary damage" @default.
• W2048509532 cites W1466471607 @default.
• W2048509532 cites W1518932181 @default.
• W2048509532 cites W1545785503 @default.
• W2048509532 cites W1963521777 @default.
• W2048509532 cites W1971530528 @default.
• W2048509532 cites W1985039091 @default.
• W2048509532 cites W1994746887 @default.
• W2048509532 cites W2001988515 @default.
• W2048509532 cites W2002792806 @default.
• W2048509532 cites W2003735968 @default.
• W2048509532 cites W2013972435 @default.
• W2048509532 cites W2041978804 @default.
• W2048509532 cites W2044266070 @default.
• W2048509532 cites W2047025052 @default.
• W2048509532 cites W2049300308 @default.
• W2048509532 cites W2053062434 @default.
• W2048509532 cites W2060121270 @default.
• W2048509532 cites W2061332953 @default.
• W2048509532 cites W2062999758 @default.
• W2048509532 cites W2069819211 @default.
• W2048509532 cites W2069870067 @default.
• W2048509532 cites W2083881519 @default.
• W2048509532 cites W2096300605 @default.
• W2048509532 cites W2097901599 @default.
• W2048509532 cites W2104908471 @default.
• W2048509532 cites W2124196467 @default.
• W2048509532 cites W2130066047 @default.
• W2048509532 cites W2146853374 @default.
• W2048509532 cites W2147131783 @default.
• W2048509532 cites W2148684867 @default.
• W2048509532 cites W2154652225 @default.
• W2048509532 cites W2154959108 @default.
• W2048509532 cites W2164203667 @default.
• W2048509532 cites W2166391846 @default.
• W2048509532 cites W2323322844 @default.
• W2048509532 doi "https://doi.org/10.1002/hep.28138" @default.
• W2048509532 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4681612" @default.
• W2048509532 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26313562" @default.
• W2048509532 hasPublicationYear "2015" @default.
• W2048509532 type Work @default.
• W2048509532 sameAs 2048509532 @default.
• W2048509532 citedByCount "14" @default.
• W2048509532 countsByYear W20485095322016 @default.
• W2048509532 countsByYear W20485095322017 @default.
• W2048509532 countsByYear W20485095322018 @default.
• W2048509532 countsByYear W20485095322019 @default.
• W2048509532 countsByYear W20485095322020 @default.
• W2048509532 countsByYear W20485095322022 @default.
• W2048509532 countsByYear W20485095322023 @default.
• W2048509532 crossrefType "journal-article" @default.
• W2048509532 hasAuthorship W2048509532A5005614526 @default.
• W2048509532 hasAuthorship W2048509532A5010510821 @default.
• W2048509532 hasAuthorship W2048509532A5013568442 @default.
• W2048509532 hasAuthorship W2048509532A5034146725 @default.
• W2048509532 hasAuthorship W2048509532A5035712059 @default.
• W2048509532 hasAuthorship W2048509532A5058175056 @default.
• W2048509532 hasBestOaLocation W20485095321 @default.
• W2048509532 hasConcept C126322002 @default.
• W2048509532 hasConcept C134018914 @default.
• W2048509532 hasConcept C139447449 @default.
• W2048509532 hasConcept C158617107 @default.
• W2048509532 hasConcept C184235292 @default.
• W2048509532 hasConcept C185592680 @default.
• W2048509532 hasConcept C2780186670 @default.
• W2048509532 hasConcept C57074206 @default.
• W2048509532 hasConcept C62478195 @default.
• W2048509532 hasConcept C71924100 @default.
• W2048509532 hasConcept C86803240 @default.
• W2048509532 hasConcept C95444343 @default.
• W2048509532 hasConcept C97029542 @default.
• W2048509532 hasConceptScore W2048509532C126322002 @default.
• W2048509532 hasConceptScore W2048509532C134018914 @default.
• W2048509532 hasConceptScore W2048509532C139447449 @default.
• W2048509532 hasConceptScore W2048509532C158617107 @default.
• W2048509532 hasConceptScore W2048509532C184235292 @default.
• W2048509532 hasConceptScore W2048509532C185592680 @default.
• W2048509532 hasConceptScore W2048509532C2780186670 @default.
• W2048509532 hasConceptScore W2048509532C57074206 @default.
• W2048509532 hasConceptScore W2048509532C62478195 @default.
• W2048509532 hasConceptScore W2048509532C71924100 @default.
• W2048509532 hasConceptScore W2048509532C86803240 @default.
• W2048509532 hasConceptScore W2048509532C95444343 @default.
• W2048509532 hasConceptScore W2048509532C97029542 @default.
• W2048509532 hasIssue "6" @default.
• W2048509532 hasLocation W20485095321 @default.
• W2048509532 hasLocation W20485095322 @default.
• W2048509532 hasLocation W20485095323 @default.

• next